Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Simran Padam"'
Autor:
Jennifer Liu, Eutiquio Gutierrez, Abhay Tiwari, Simran Padam, Daneng Li, William Dale, Sumanta K. Pal, Daphne Stewart, Shanmugga Subbiah, Linda D. Bosserman, Cary Presant, Tanyanika Phillips, Kelly Yap, Addie Hill, Geetika Bhatt, Christina Yeon, Mary Cianfrocca, Yuan Yuan, Joanne Mortimer, Mina S. Sedrak
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1571 (2020)
Cancer is a disease associated with aging. As the US population ages, the number of older adults with cancer is projected to dramatically increase. Despite this, older adults remain vastly underrepresented in research that sets the standards for canc
Externí odkaz:
https://doaj.org/article/17a3a738084d4335b9e3005a0dda5ce3
Autor:
Susan E. Yost, Yuan Yuan, Christopher Ruel, Aileen Tang, Colt Egelston, Niki Patel, Norma Martinez, Jin Sun Lee, Swapnil Rajurkar, Joanne E. Mortimer, Simran Padam, Christina Yeon, Paul Frankel, Cary A. Presant, Mina S. Sedrak, Jana Portnow, Peter P. Lee
Publikováno v:
Cancer Research. 80:P3-11
Background: The combination of CDK4/6 inhibitor and aromatase inhibitor is the current standard of care therapy for patients with estrogen receptor positive (ER+) metastatic breast cancer (MBC). Single agent immune check point inhibitor (ICI) pembrol
Autor:
Heidi D. Klepin, Hyman B. Muss, Rachel A. Freedman, Supriya G. Mohile, Jennifer Liu, Tanya M. Wildes, Harvey J. Cohen, William Dale, Mina S. Sedrak, Gretchen Kimmick, Simran Padam, Andrea Lynch, Benjamin Djulbegovic, William P. Tew, Jennifer Le-Rademacher, Andrew R. Wong, Aminah Jatoi, Kevin George
Publikováno v:
CA Cancer J Clin
Cancer is a disease of aging and, as the world's population ages, the number of older persons with cancer is increasing and will make up a growing share of the oncology population in virtually every country. Despite this, older patients remain vastly
Autor:
Jennifer Liu, Kevin George, Brandon A. Chen, Andrew R. Wong, Virginia Sun, Daneng Li, Thomas George, Arya Amini, Simran Padam, Mina S. Sedrak
Publikováno v:
JCO Oncol Pract
PURPOSE: Despite considerable research on the barriers to enrollment in cancer therapeutic trials, few studies have elicited barriers from the perspective of community physicians, who provide the majority of cancer care. The purpose of this study was
Autor:
Virginia Sun, Daneng Li, Vani Katheria, William Dale, Simran Padam, Supriya G. Mohile, Can-Lan Sun, Jennifer Liu, Kevin George, Andrew R. Wong, Mina S. Sedrak, Bihong T. Chen
Publikováno v:
J Geriatr Oncol
Objectives Oncologists can be one of the major barriers to older adult's participation in research. Multiple studies have described academic clinicians' concerns for not enrolling older adults onto trials. Although the majority of older adults receiv
Autor:
Aileen Tang, Joanne E. Mortimer, Simran Padam, Jana Portnow, Susan E. Yost, Yuan Yuan, Weihua Guo, Daniel Schmolze, Cary A. Presant, Christopher Ruel, Norma Martinez, Christina Yeon, Paul Frankel, Mina S. Sedrak, Colt Egelston, Jin Sun Lee, Behnam Ebrahimi, Peter P. Lee, Niki Patel
Publikováno v:
Eur J Cancer
Background CDK4/6 inhibitors modulate immune response in breast cancer. This phase I/II trial was designed to test the safety and efficacy of palbociclib, pembrolizumab and letrozole in women with hormone receptor positive (HR+) human epidermal growt
Autor:
Sarah K. Highlander, Kim Robinson, Joanne E. Mortimer, Simran Padam, Aileen Tang, Lauren Reining, Susan E. Yost, Mina S. Sedrak, Norma Martinez, James Waisman, Yuan Yuan, John D. Gillece
Publikováno v:
Cancer Research. 80:P5-06
Background: Collection of fecal samples is non-invasive, and DNA sequencing of microorganisms can provide a profile of the gut microbiome which may be an indicator of general health and disease, including inflammation, digestive inefficiencies, and t
Autor:
Vivek Musinipally, Louise C. Walter, Supriya G. Mohile, Melisa L. Wong, Daniel Castillo, Chandrika Sanapala, Carolyn J Presley, Madison Grogan, Kah Poh Loh, Mina S. Sedrak, Katey R Webber, Simran Padam, Grace DiGiovanni, Vivian Lam, Janice Grandi
Publikováno v:
J Natl Compr Canc Netw
Background: Maintaining functional status is important to older adults with cancer, but data are limited on how systemic treatments affect functional status. We systematically reviewed changes in functional status during systemic cancer treatments an
Autor:
Niki Dipesh Patel, Jin Sun Lee, Yuan Yuan, Daneng Li, Shamel Sanani, Joanne E. Mortimer, Mina S. Sedrak, Simran Padam, M. Suzette Blanchard, Aileen Tang, Can-Lan Sun, Tracey Stiller, Cary A. Presant, Heeyoung Kim, Vani Katheria, James Waisman, Susan E. Yost, Norma Martinez
Publikováno v:
J Geriatr Oncol
Objective The tolerability and efficacy of targeted therapy in older adults with cancer has not been adequately studied. Neratinib is a novel HER1, HER2, HER4 tyrosine kinase inhibitor that has recently been granted FDA approval for treatment of brea
Autor:
Addie Hill, William Dale, Christina Yeon, Eutiquio Gutierrez, Geetika Bhatt, Sumanta K. Pal, Joanne E. Mortimer, Daneng Li, Simran Padam, Abhay Tiwari, Tanyanika Phillips, Yuan Yuan, Shanmugga Subbiah, Mary Cianfrocca, Cary A. Presant, Jennifer Liu, Kelly Yap, Mina S. Sedrak, Linda D. Bosserman, Daphne Stewart
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1571, p 1571 (2020)
Journal of Clinical Medicine, Vol 9, Iss 1571, p 1571 (2020)
Cancer is a disease associated with aging. As the US population ages, the number of older adults with cancer is projected to dramatically increase. Despite this, older adults remain vastly underrepresented in research that sets the standards for canc